대한약학회 추계총회 및 학술대회 (2013년) Thio-Cl-IB-MECA, a Novel A3 Adenosine Receptor Agonist, Inhibits Angiogenesis via the Regulating PI3K/AKT/mTOR and ERK Signaling Pathway in Endothelial Cells

학술대회자료

Thio-Cl-IB-MECA, a Novel A3 Adenosine Receptor Agonist, Inhibits Angiogenesis via the Regulating PI3K/AKT/mTOR and ERK Signaling Pathway in Endothelial Cells

대한약학회
추계총회 및 학술대회
(2013년)
2013.10

553 - 553 (1 pages)

원문보기

원문저장

Thio-Cl-IB-MECA, a Novel A3 Adenosine Receptor Agonist, Inhibits Angiogenesis via the Regulating PI3K/AKT/mTOR and ERK Signaling Pathway in Endothelial Cells

(0)

(0)

(0)

(0)

Thio-Cl-IB-MECA, a Novel A3 Adenosine Receptor Agonist, Inhibits Angiogenesis via the Regulating PI3K/AKT/mTOR and ERK Signaling Pathway in Endothelial Cells

(0)

(0) 팝업 열기 팝업 닫기

(0)

(0)

(0)